The observation that Id-specific TCR-transgenic mice were more resistant to myeloma in the absence than in the presence of SH2D2A could be due to altered vascular function, as SH2D2A is also expressed in endothelial cells [31], [32]. This evidence concerns the gene SH2D2A and plasma cell myeloma.